118 related articles for article (PubMed ID: 22151277)
1. DFT-based QSAR models to predict the antimycobacterial activity of chalcones.
Barua N; Sarmah P; Hussain I; Deka RC; Buragohain AK
Chem Biol Drug Des; 2012 Apr; 79(4):553-9. PubMed ID: 22151277
[TBL] [Abstract][Full Text] [Related]
2. Novel aryloxy azolyl chalcones with potent activity against Mycobacterium tuberculosis H37Rv.
Marrapu VK; Chaturvedi V; Singh S; Singh S; Sinha S; Bhandari K
Eur J Med Chem; 2011 Sep; 46(9):4302-10. PubMed ID: 21764184
[TBL] [Abstract][Full Text] [Related]
3. Novel 4-(morpholin-4-yl)-N'-(arylidene)benzohydrazides: synthesis, antimycobacterial activity and QSAR investigations.
Raparti V; Chitre T; Bothara K; Kumar V; Dangre S; Khachane C; Gore S; Deshmane B
Eur J Med Chem; 2009 Oct; 44(10):3954-60. PubMed ID: 19464085
[TBL] [Abstract][Full Text] [Related]
4. Relationships between molecular properties and antimycobacterial activities of steroids.
Rugutt JK; Rugutt KJ
Nat Prod Lett; 2002 Apr; 16(2):107-13. PubMed ID: 11990426
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, antimycobacterial activity evaluation, and QSAR studies of chalcone derivatives.
Sivakumar PM; Seenivasan SP; Kumar V; Doble M
Bioorg Med Chem Lett; 2007 Mar; 17(6):1695-700. PubMed ID: 17276682
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines.
Nayyar A; Monga V; Malde A; Coutinho E; Jain R
Bioorg Med Chem; 2007 Jan; 15(2):626-40. PubMed ID: 17107805
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and 3D-QSAR analysis of 2-chloroquinoline derivatives as H37 RV MTB inhibitors.
Khunt RC; Khedkar VM; Coutinho EC
Chem Biol Drug Des; 2013 Dec; 82(6):669-84. PubMed ID: 23790070
[TBL] [Abstract][Full Text] [Related]
8. Screening for in vitro antimycobacterial activity and three-dimensional quantitative structure-activity relationship (3D-QSAR) study of 4-(arylamino)coumarin derivatives.
Virsdoia V; Shaikh MS; Manvar A; Desai B; Parecha A; Loriya R; Dholariya K; Patel G; Vora V; Upadhyay K; Denish K; Shah A; Coutinho EC
Chem Biol Drug Des; 2010 Nov; 76(5):412-24. PubMed ID: 20925693
[TBL] [Abstract][Full Text] [Related]
9. Syntheses of lipophilic chalcones and their conformationally restricted analogues as antitubercular agents.
Ahmad I; Thakur JP; Chanda D; Saikia D; Khan F; Dixit S; Kumar A; Konwar R; Negi AS; Gupta A
Bioorg Med Chem Lett; 2013 Mar; 23(5):1322-5. PubMed ID: 23369537
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity and QSAR of chalcones against biofilm-producing bacteria isolated from marine waters.
Sivakumar PM; Prabhawathi V; Doble M
SAR QSAR Environ Res; 2010 Apr; 21(3-4):247-63. PubMed ID: 20544550
[TBL] [Abstract][Full Text] [Related]
11. Antifungal activity, mechanism and QSAR studies on chalcones.
Sivakumar PM; Muthu Kumar T; Doble M
Chem Biol Drug Des; 2009 Jul; 74(1):68-79. PubMed ID: 19519746
[TBL] [Abstract][Full Text] [Related]
12. Pyranocoumarin, a novel anti-TB pharmacophore: synthesis and biological evaluation against Mycobacterium tuberculosis.
Xu ZQ; Pupek K; Suling WJ; Enache L; Flavin MT
Bioorg Med Chem; 2006 Jul; 14(13):4610-26. PubMed ID: 16513358
[TBL] [Abstract][Full Text] [Related]
13. Design of novel camphane-based derivatives with antimycobacterial activity.
Stavrakov G; Valcheva V; Philipova I; Doytchinova I
J Mol Graph Model; 2014 Jun; 51():7-12. PubMed ID: 24859319
[TBL] [Abstract][Full Text] [Related]
14. Antimycobacterial activity of novel 1,2,4-oxadiazole-pyranopyridine/chromene hybrids generated by chemoselective 1,3-dipolar cycloadditions of nitrile oxides.
Ranjith Kumar R; Perumal S; Menéndez JC; Yogeeswari P; Sriram D
Bioorg Med Chem; 2011 Jun; 19(11):3444-50. PubMed ID: 21592801
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitubercular activity of substituted novel pyrazoline derivatives.
Ali MA; Yar MS; Kumar M; Pandian GS
Nat Prod Res; 2007 Jun; 21(7):575-9. PubMed ID: 17613813
[TBL] [Abstract][Full Text] [Related]
16. Quantitative structure-activity relationship for cyclic imide derivatives of protoporphyrinogen oxidase inhibitors: a study of quantum chemical descriptors from density functional theory.
Wan J; Zhang L; Yang G; Zhan CG
J Chem Inf Comput Sci; 2004; 44(6):2099-105. PubMed ID: 15554680
[TBL] [Abstract][Full Text] [Related]
17. Quantitative structure-activity relationship of molecules constituent of different essential oils with antimycobacterial activity against Mycobacterium tuberculosis and Mycobacterium bovis.
Andrade-Ochoa S; Nevárez-Moorillón GV; Sánchez-Torres LE; Villanueva-García M; Sánchez-Ramírez BE; Rodríguez-Valdez LM; Rivera-Chavira BE
BMC Complement Altern Med; 2015 Sep; 15():332. PubMed ID: 26400221
[TBL] [Abstract][Full Text] [Related]
18. Substituted quinolinyl chalcones and quinolinyl pyrimidines as a new class of anti-infective agents.
Sharma M; Chaturvedi V; Manju YK; Bhatnagar S; Srivastava K; Puri SK; Chauhan PM
Eur J Med Chem; 2009 May; 44(5):2081-91. PubMed ID: 19028410
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and antimycobacterial activity of some novel imidazo[1,2-c]pyrimidines.
Chhabria MT; Jani MH
Eur J Med Chem; 2009 Oct; 44(10):3837-44. PubMed ID: 19423196
[TBL] [Abstract][Full Text] [Related]
20. Design of potent fluoro-substituted chalcones as antimicrobial agents.
Burmaoglu S; Algul O; Gobek A; Aktas Anil D; Ulger M; Erturk BG; Kaplan E; Dogen A; Aslan G
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):490-495. PubMed ID: 28118738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
